Navigation Links
Healthcare Travel Exhibition & Congress Predicts Worldwide Healthcare Travel Revenue to Hit US$100 Billion by 2012
Date:6/28/2009

SINGAPORE, June 29 /PRNewswire-Asia/ -- Rising healthcare standards together with the growing demand for more affordable treatment will keep the Asian market for medical tourism buoyant, according to experts speaking at the Healthcare Travel Exhibition & Congress today at Fairmont Hotel, Singapore. Worldwide gross medical tourism revenue is projected to grow from US$56 billion to reach US$100 billion by 2012, with Asia as a major driver of this growth.

"Buoyed by the success stories of earlier waves of medical tourists, consumers, insurance companies as well businesses fully recognise the reliability and affordability of going overseas for medical procedures. Patients who choose to undergo treatments in Asia can pay just 10% of the cost of comparable treatment conducted in developed countries like the United States or United Kingdom. This differential cost, coupled with today's sophisticated travel industry, provides an excellent catalyst to the growth of medical tourism," said Mr. Andrew Keable, Divisional Director, Informa Life Sciences.

Asia is well-placed to grow in medical tourism as healthcare standards and technology adoption continue to improve. Hospitals in Korea, Malaysia, Thailand, India and Singapore have made it a point to implement state-of-the- art medical technologies to improve patient care.

Healthcare Travel Exhibition & Congress 2009 is Asia's premier event focusing on two of the world's largest industries: healthcare and tourism. The event brings together professionals, government officials and decision makers from the healthcare and travel industries, giving them the opportunity to network and share best practices, insights and knowledge to further develop Asia's thriving healthcare travel market.

Leading edge technology is on display at the exhibition portion of the event, where close to 30 exhibitors including leading medical suppliers, healthcar
'/>"/>

SOURCE Informa Life Sciences
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. WellNet Introduces Healthcare Performance Management on Capitol Hill
2. Five Genesis HealthCare Centers To Be Awarded Prestigious National Award
3. Healthcare Staffing Company Medical Solutions Named Among "2009 Best Places to Work in Omaha"
4. Federal Trade Commission Reports: Authorized Generics, During the 180-day Exclusivity Period, Benefit Consumers and the American Healthcare System
5. UnitedHealthcare and Fusion Sleep Announce New Agreement
6. Akerman Senterfitt Announces Expansion of Healthcare Practice
7. Traveling Healthcare Staffing Company, Medical Solutions, Announces a Ttitle change for its Recruiters to Career Consultants
8. Siemens Healthcare Testifies on Healthcare Reform and Building a Healthier America
9. U.S. Womens Chamber of Commerce Advocates Strong Healthcare Reforms in Support of American Values
10. Sharp HealthCare and Anakam(R) Partner to Protect Patients Health Information
11. CED/Zogby Release Survey of Business Perspectives on Healthcare Reform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/26/2014)... 2014 Parker & Sons, Inc. ... in heating, cooling and plumbing contractor services throughout ... services in 2014 with regard to air-conditioning systems. ... is known for its incredibly hot summers. Working ... intricacies and details of a wide variety of ...
(Date:12/25/2014)... TX (PRWEB) December 26, 2014 This ... state of the global Sterilizers industry with a focus ... on the market status of the Sterilizers manufacturers and ... companies and individuals interested in the industry. This report ... definition, applications and manufacturing technology. In this part, the ...
(Date:12/25/2014)... The report “Nintedanib (Colorectal Cancer) ... on the current treatment landscape, unmet needs, current ... market. Stivarga is a drug which is used ... Boehringer Ingelheim is developing nintedanib (BIBF-1120), an orally ... CRC in the US, Europe, and Japan. The ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 Product liability ... ASR hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to move ... to an Order issued in the U.S. District Court, ... will convene an open conference on January 7, 2015, ... States Courthouse in West Palm Beach, Florida. The Conference ...
(Date:12/25/2014)... 26, 2014 Recently, iFitDress.com, the popular online ... has announced its new selection of black one-shoulder cocktail ... sale now; they are available at discounted prices, up to ... promotion will last for three weeks only. You know, we ... who are interested in our new items can visit our ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2
... Minister Tony Blair in the next fortnight to discuss ... to work with the Prime Minister on a new ... Blair. ,Schwarzenegger would discuss a programme of ... on June 27, adds the source. ,The ...
... at Chicago and Cornell University are developing a new ... from Neurodegenerative diseases or stroke . ,During ... that lead to the death of brain cells. Compounds ... can modulate gene expression, and in some cases produce ...
... so far been restricted only to difficulty in walking on ... has revealed that high heels are also making driving dangerous ... stilettos an inappropriate footwear for driving and said that women ... ,The survey conducted by women's car insurance concern Sheilas ...
... between the National Institute of Health & Family Welfare ... of technology developed by the NIHFW in the ... for Testing Sperm Functions. The up scaling of technologies ... NRDC for commercialization. Prof. Deoki Nandan, Director, NIHFW and ...
... working with vaccine manufacturers to move ahead on plans to ... avian influenza virus. ,The announcement follows a request ... establish an international stockpile of H5N1 vaccine. ,WHO ... contribute to the H5N1 global vaccine stockpile. Omninvest of Hungary, ...
... quack here has confessed to aborting over 250 female fetuses, adding ... carried out at his nursing home over the last decade. ... Buala Nursing Home in Pataudi town near here and discovered the ... ,"The accused has confessed that he has aborted more than ...
Cached Medicine News:Health News:Researchers Developing New Therapy to Re-activate Silenced Genes 2Health News:National Institute Of Health & Family Welfare To Commercialize Its Products 2Health News:Quack of Gurgaon Confesses of Aborting 250 Female Fetuses 2
(Date:12/24/2014)... 2014  Novastem, a leader in regenerative medicine, ... its study for ischemic stroke at Clinica Santa ... strokes account for 87 percent of all stroke ... the study, entitled "Internal Research Protocol in Combination ... Cells and Intrathecal Administration of Neural Stem Cells ...
(Date:12/24/2014)... China, Dec. 24, 2014 /PRNewswire/  -- Tianyin Pharmaceutical ... pharmaceutical company that specializes in the patented biopharmaceutical, ... active pharmaceutical ingredients (API) released unaudited preliminary financial ... 2015. Fiscal Year 2015 Ended September ... $9.7 million compared with $14.7 million in 1Q14 ...
(Date:12/24/2014)... 2014  The International Trade Commission (ITC) issued its final ... Medical. In a notice issued on December 23, the ITC ... on its humidifier was invalid. BMC President, ... are very excited with the ITC,s decision in this case. ... taken since the very beginning on the key patents in ...
Breaking Medicine Technology:Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 2TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 3TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 5TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 6TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 7TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 8TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 9TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 10TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 11TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 12ITC Final Decision Goes Against ResMed (RMD) Monumental Win for 3B/BMC 2
... Lyphochek Immunoassay Plus Control provides the ... control in the world for monitoring ... eliminating the need for separate controls. ... added preservatives, it is suitable for ...
Lyphochek Immunology Plus Control is an assayed control for monitoring chemistry procedures that test for autoimmune, anemic, malignant, hepatic and nephrotic-disease states. Available in two levels....
... The Vidiera NsD Nucleic Sample Detection Platform ... post amplification. The new platform for ... capillary electrophoresis (CE), with software features that ... flexibility. Vidiera NsD has the capacity ...
... Sample Preparation Platform provides flexible, automated extraction ... can prepare up to 96 patient samples ... one half-hours, and performs onboard quantitation and ... minutes each. Based on Beckman Coulters ...
Medicine Products: